News Home Friday, February 23, 2024 11:37 AM | InvestorsObserver Analysts Mentioned in this article Sana Biotechnology Inc (SANA) is...
Sana
SEATTLE, Nov. 02, 2023 (World NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a enterprise targeted on altering the possible for...
Raising concentrate on ex vivo cell treatment platform centered on considerable preclinical and early translational medical knowledge suggesting capacity of...
News Home Monday, April 17, 2023 02:01 PM | InvestorsObserver Analysts Mentioned in this article Wall Street is positive on...
Late-breaking poster presentation to highlight preclinical data demonstrating that the increased potency of CD8-targeted fusosomes enhances CAR gene delivery to...
Announced SC291 IND clearance with goal to report initial clinical data this year Expect to initiate investigator-sponsored trial with hypoimmune-modified...
